The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
PPP3R1, identified in the question by UniProt accession P63098, encodes calcineurin B1 (CnB1), the calcium-binding regulatory subunit of calcineurin, also called protein phosphatase 2B or PPP3. This assignment is consistent with independent reviews, which distinguish PPP3R1 from PPP3R2 (calcineurin B2) and from PPP3CA, PPP3CB and PPP3CC (catalytic calcineurin A isoforms). Its four calcium-binding EF-hand motifs agree with the supplied domain annotations. The cited literature verifies the gene–protein assignment and family; P63098 itself is the identifier supplied in the question, rather than an accession independently checked against a database record here. (fonodi2024roleofprotein pages 15-16, roy2020identifyingnewsubstrates pages 1-3, nolze2023calcineurinisa pages 1-3)
The primary function of PPP3R1 is to sense intracellular Ca²⁺ and regulate the activity and positioning of its catalytic partner, calcineurin A—not to catalyze a reaction itself. Calcineurin A supplies the metal-dependent phosphatase active site and removes phosphate from selected phosphoserine/phosphothreonine residues on proteins. NFAT transcription factors are its best-characterized substrates; TFEB is another established substrate. Consequently, substrate specificity belongs to the assembled, regulated phosphatase complex and its substrate-docking interactions, not to an intrinsic enzymatic activity of isolated CnB1. (roy2020identifyingnewsubstrates pages 1-3, fonodi2024roleofprotein pages 15-16, nolze2023calcineurinisa pages 1-3, xia2024smurf1controlsthe pages 11-13)
CnB contains two pairs of EF-hands with different calcium affinities: approximately 10–50 µM for the low-affinity pair and submicromolar affinity for the high-affinity pair, as summarized by Roy and Cyert. Their mechanistic synthesis proposes that calcium binding to CnB promotes subsequent Ca²⁺–calmodulin binding to CnA, displacement of CnA autoinhibitory elements and maximal phosphatase activity. It also reports that N-terminal myristoylation of CnB promotes enzyme thermal stability; this modification should not, by itself, be interpreted as proof that CnB1 is constitutively membrane-bound. In biochemical experiments, calcium-free CnB still bound CnA and supported weaker phosphatase regulation than calcium-saturated CnB, demonstrating that complex assembly and calcium-dependent activation are related but distinct properties. (roy2020identifyingnewsubstrates pages 3-4, li2009calcineurinregulatorysubunit pages 1-2)
The experimental contexts most relevant to functional annotation are summarized below; mouse gene-deletion results are not presented as direct human knockout evidence. (li2009calcineurinregulatorysubunit pages 1-2, mencarelli2018calcineurinbin pages 1-2, reed2020deletionofcalcineurin pages 1-7, xia2024smurf1controlsthe pages 8-11)
| Context | Direct PPP3R1/CnB1 molecular action and experimental basis | Evidence type / species | Exact study DOI / year |
|---|---|---|---|
| Ca²⁺ sensing and EF-hands | CnB is the regulatory, not catalytic, calcineurin subunit. It contains four EF-hands and binds CnA even without Ca²⁺; Ca²⁺-saturated CnB regulates CnA more strongly. Activity, pull-down and circular-dichroism assays supported this mechanism. A later synthesis assigns paired high-affinity (submicromolar) and low-affinity (10–50 µM) sites and reports that low-affinity-site occupancy lowers the holoenzyme’s substrate Kₘ; CnA supplies phosphatase catalysis. (li2009calcineurinregulatorysubunit pages 1-2, roy2020identifyingnewsubstrates pages 3-4) | Direct biochemical study of purified CnB/CnA plus structural simulation; authoritative mechanistic review. The biochemical result concerns CnB protein and is not a human-cell knockout experiment. | 10.1002/prot.22474, 2009; 10.1101/cshperspect.a035436, 2020 |
| Calcineurin–NFAT signaling | PPP3R1 provides the Ca²⁺-binding regulatory subunit that enables activation of the CnA catalytic subunit. Activated holoenzyme dephosphorylates NFAT, exposing its nuclear-localization signal and enabling nuclear import; this is a calcineurin-holoenzyme mechanism, not evidence that PPP3R1 itself catalyzes dephosphorylation. (nolze2023calcineurinisa pages 1-3) | Authoritative review integrating biochemical and cellular studies across mammalian systems; not a direct PPP3R1 perturbation experiment. | 10.3390/cells12182269, 2023 |
| CD4⁺ T-cell homeostasis | Conditional Ppp3r1/Cnb1 deletion enhanced IL-12-responsive JAK2–STAT4 signaling and IFN-γ production and caused microbiota-associated spontaneous colitis. This establishes a cell-autonomous regulatory requirement for CnB1 but does not assign catalytic activity to it. (mencarelli2018calcineurinbin pages 10-11, mencarelli2018calcineurinbin pages 1-2, mencarelli2018calcineurinbin pages 2-3) | Direct conditional knockout: Cd4-Cre mouse CD4⁺ T cells and mice; mouse, not human. | 10.3389/fimmu.2018.00261, 2018 |
| Cardiomyocyte sarcolemma | Endogenous CnB associated with CIB1 by co-immunoprecipitation; CIB1-dependent targeting placed CnB at the sarcolemma near the α1C L-type Ca²⁺ channel and supported stimulus-induced NFAT signaling. Non-myristoylatable CIB1 failed to restore membrane targeting, while CIB1 did not directly increase recombinant CnA catalytic activity—supporting localization/scaffolding rather than catalysis by PPP3R1. (heineke2010cib1isa pages 4-6, heineke2010cib1isa pages 6-7) | Direct binding, localization and reporter experiments in cultured rodent cardiomyocytes and mouse hearts; ancillary Ppp3r1-deleted mouse fibroblasts. Not direct human-cell evidence. | 10.1038/nm.2181, 2010 |
| Damaged lysosome–TFEB axis | After LLOMe-induced lysosomal damage, PPP3R1 was recruited to lysosomes in an LGALS3/Gal3-dependent manner. It directly bound catalytic PPP3CB and TFEB, indirectly associated with Gal3, and supported Gal3–SMURF1 complex assembly and TFEB positioning/stabilization. PPP3CB, not PPP3R1, performs TFEB dephosphorylation. PPP3R1 knockdown reduced SMURF1–Gal3 binding; the broader pathway promoted TFEB nuclear import and lysosomal biogenesis. (xia2024smurf1controlsthe pages 8-11, xia2024smurf1controlsthe pages 11-13) | Direct cultured-cell immunofluorescence, knockdown/overexpression, co-IP, pull-down and domain mapping; mechanistic cell-culture evidence, not a human organismal knockout study. | 10.1080/15548627.2023.2267413, 2024 |
| Schwann-cell injury response | Conditional Schwann-cell Ppp3r1/CnB1 deletion reduced early TFEB nuclear localization and autophagic flux after nerve crush and delayed myelin-debris clearance, while having little effect on developmental myelination. This supports a regulatory requirement for CnB1 in calcineurin-dependent TFEB activation. (reed2020deletionofcalcineurin pages 21-25, reed2020deletionofcalcineurin pages 1-7) | Direct conditional knockout in male and female mice plus primary Schwann-cell experiments; mouse, not human. | 10.1523/JNEUROSCI.0951-20.2020, 2020 |
Table: Evidence-weighted summary separating PPP3R1/CnB1’s regulatory and localization functions from CnA-mediated catalysis. Species and experimental context are identified to prevent mouse or generic calcineurin findings from being misrepresented as direct human PPP3R1 evidence.
Localization is stimulus- and partner-dependent. Calcineurin is predominantly intracellular and cytoplasmic under basal conditions, although a smaller nuclear pool has been reported. Its defining activity is therefore not extracellular secretion: it couples local intracellular calcium signals to protein dephosphorylation. In mouse cardiomyocytes, endogenous CnB associates with CIB1, which helps position the complex at the sarcolemma near an L-type Ca²⁺ channel during hypertrophic stimulation. These data establish a context-specific membrane-associated pool, not an exclusively membrane-localized human PPP3R1 protein. (masaki2022decodingthephosphatase pages 4-5, thiel2021ca2+microdomainscalcineurin pages 8-10, heineke2010cib1isa pages 4-6, heineke2010cib1isa pages 6-7)
The canonical pathway is Ca²⁺ → CnB1/Ca²⁺–calmodulin-regulated calcineurin A → NFAT dephosphorylation → NFAT nuclear import and transcriptional response. NFAT itself moves from cytoplasm to nucleus after dephosphorylation; this should not be confused with a requirement that all CnB1 translocate to the nucleus. This pathway connects calcium signals to immune-cell activation and tissue-specific transcriptional programs. Calcineurin can recognize additional proteins through docking interactions, so NFAT is the best-defined substrate family rather than its only possible target. (nolze2023calcineurinisa pages 1-3, thiel2021ca2+microdomainscalcineurin pages 8-10, fonodi2024roleofprotein pages 15-16)
A second well-supported pathway involves TFEB, whose calcineurin-dependent activation promotes transcription associated with lysosomal biogenesis and autophagy. In mice with Schwann-cell-specific Ppp3r1 deletion, nerve injury produced less early nuclear TFEB, reduced autophagic flux and slower clearance of myelin debris, despite little effect on developmental myelination. The TFEB nuclear-localization difference was observed at three days after nerve crush and was no longer detectable at seven days, a useful indication that the requirement is time- and context-dependent. (reed2020deletionofcalcineurin pages 21-25, reed2020deletionofcalcineurin pages 1-7)
A 2024 primary study added unusually direct, PPP3R1-specific spatial and interaction evidence to the lysosomal model. After experimentally induced lysosomal damage, immunofluorescence showed LGALS3/galectin-3-dependent recruitment of PPP3R1 to lysosomes. Binding experiments found a damage-enhanced PPP3R1–PPP3CB association; PPP3R1 associated indirectly with galectin-3 and bound TFEB in interaction assays. PPP3R1 knockdown weakened the galectin-3–SMURF1 interaction. In the authors’ model, PPP3R1 supports assembly and TFEB positioning, whereas PPP3CB is the catalytic subunit responsible for TFEB-directed phosphatase activity. The work is mechanistic cell-study evidence, not a demonstration that targeting PPP3R1 treats lysosomal disease in patients. The article appeared in Autophagy 20:735–751 (2024); its DOI contains its earlier publication identifier, 10.1080/15548627.2023.2267413. (xia2024smurf1controlsthe pages 8-11, xia2024smurf1controlsthe pages 11-13)
For broader physiological context, a 2023 review concluded from knockout and inhibitor studies that calcineurin/NFAT signaling participates in vascular smooth-muscle responses, including proliferation, migration and remodeling. This is evidence about calcineurin signaling across subunits and cell types, not proof that changing human PPP3R1 alone produces each vascular phenotype. The review was published 13 September 2023. (nolze2023calcineurinisa pages 1-3, nolze2023calcineurinisa pages 3-4)
Genetic perturbation strengthens the assignment of CnB1 as a necessary regulatory component. CD4⁺ T-cell-specific Ppp3r1/Cnb1 deletion in mice caused spontaneous colitis associated with increased IL-12 responsiveness, JAK2–STAT4 signaling and IFN-γ production. This shows that CnB1-dependent signaling also restrains a particular inflammatory response; it does not mean that CnB1 directly dephosphorylates STAT4. In separate mouse-heart and cultured-cardiomyocyte experiments, CIB1–CnB binding and CIB1-dependent sarcolemmal positioning correlated with NFAT reporter activation under hypertrophic stimulation. Deleting Ppp3r1 in mouse embryonic fibroblasts also prevented CIB1 overexpression from stabilizing calcineurin A, supporting a role for CnB1 in maintaining its catalytic partner. (mencarelli2018calcineurinbin pages 10-11, mencarelli2018calcineurinbin pages 1-2, heineke2010cib1isa pages 4-6, heineke2010cib1isa pages 6-7)
Clinical implementation targets the calcineurin complex, not PPP3R1 selectively. Cyclosporine and tacrolimus are established calcineurin-inhibiting immunosuppressants used, for example, to prevent allograft rejection; related agents are used for immune-mediated disease. Their immunophilin–drug complexes block calcineurin-dependent signaling, including NFAT activation. Because these drugs inhibit complex activity rather than selectively deleting CnB1, their benefits or adverse effects cannot be assigned solely to PPP3R1. The 2023 vascular review discusses hypertension and renal salt-handling effects among relevant limitations. (nolze2023calcineurinisa pages 3-4, roy2020identifyingnewsubstrates pages 1-3)
Interpretation: The strongest molecular annotation is intracellular EF-hand Ca²⁺ sensor and regulatory/scaffolding partner of catalytic calcineurin A. Direct PPP3R1-specific evidence supports complex assembly, localized recruitment and requirements revealed by conditional mouse deletion. Much of the clinically relevant NFAT literature tests the holoenzyme or nonspecific calcineurin inhibitors, while the newer lysosomal mechanism has not been established here as a human clinical intervention. Reported calcium affinities characterize CnB EF-hand pairs in biochemical analyses; they are not measurements of calcium concentrations at every cellular site. (li2009calcineurinregulatorysubunit pages 1-2, roy2020identifyingnewsubstrates pages 3-4, xia2024smurf1controlsthe pages 8-11, nolze2023calcineurinisa pages 3-4)
Selected publications, with accessible identifiers and publication dates, are: Roy and Cyert, Cold Spring Harbor Perspectives in Biology (2020), https://doi.org/10.1101/cshperspect.a035436; Li et al., Proteins (published online 11 May 2009), https://doi.org/10.1002/prot.22474; Nolze et al., Cells (13 September 2023), https://doi.org/10.3390/cells12182269; Xia et al., Autophagy (2024), https://doi.org/10.1080/15548627.2023.2267413; Mencarelli et al., Frontiers in Immunology (February 2018), https://doi.org/10.3389/fimmu.2018.00261; Heineke et al., Nature Medicine (2010), https://doi.org/10.1038/nm.2181; and Reed et al., Journal of Neuroscience (2020), https://doi.org/10.1523/JNEUROSCI.0951-20.2020. (roy2020identifyingnewsubstrates pages 3-4, li2009calcineurinregulatorysubunit pages 1-2, nolze2023calcineurinisa pages 1-3, xia2024smurf1controlsthe pages 8-11, mencarelli2018calcineurinbin pages 1-2, heineke2010cib1isa pages 4-6, reed2020deletionofcalcineurin pages 1-7)
References
(fonodi2024roleofprotein pages 15-16): Márton Fonódi, Lilla Nagy, and Anita Boratkó. Role of protein phosphatases in tumor angiogenesis: assessing pp1, pp2a, pp2b and ptps activity. International Journal of Molecular Sciences, 25:6868, Jun 2024. URL: https://doi.org/10.3390/ijms25136868, doi:10.3390/ijms25136868. This article has 12 citations.
(roy2020identifyingnewsubstrates pages 1-3): Jagoree Roy and Martha S. Cyert. Identifying new substrates and functions for an old enzyme: calcineurin. Cold Spring Harbor perspectives in biology, 12:a035436, Jul 2020. URL: https://doi.org/10.1101/cshperspect.a035436, doi:10.1101/cshperspect.a035436. This article has 87 citations and is from a peer-reviewed journal.
(nolze2023calcineurinisa pages 1-3): Alexander Nolze, Sebastian Matern, and Claudia Grossmann. Calcineurin is a universal regulator of vessel function—focus on vascular smooth muscle cells. Cells, 12:2269, Sep 2023. URL: https://doi.org/10.3390/cells12182269, doi:10.3390/cells12182269. This article has 24 citations.
(xia2024smurf1controlsthe pages 11-13): Qin Xia, Hanfei Zheng, Yang Li, Wanting Xu, Chengwei Wu, Jiachen Xu, Shanhu Li, Lingqiang Zhang, and Lei Dong. Smurf1 controls the ppp3/calcineurin complex and tfeb at a regulatory node for lysosomal biogenesis. Autophagy, 20:735-751, Nov 2024. URL: https://doi.org/10.1080/15548627.2023.2267413, doi:10.1080/15548627.2023.2267413. This article has 30 citations and is from a domain leading peer-reviewed journal.
(roy2020identifyingnewsubstrates pages 3-4): Jagoree Roy and Martha S. Cyert. Identifying new substrates and functions for an old enzyme: calcineurin. Cold Spring Harbor perspectives in biology, 12:a035436, Jul 2020. URL: https://doi.org/10.1101/cshperspect.a035436, doi:10.1101/cshperspect.a035436. This article has 87 citations and is from a peer-reviewed journal.
(li2009calcineurinregulatorysubunit pages 1-2): Jing Li, ZhiGuang Jia, WenChang Zhou, and Qun Wei. Calcineurin regulatory subunit b is a unique calcium sensor that regulates calcineurin in both calcium‐dependent and calcium‐independent manner. Proteins: Structure, 77:612-623, Nov 2009. URL: https://doi.org/10.1002/prot.22474, doi:10.1002/prot.22474. This article has 27 citations.
(mencarelli2018calcineurinbin pages 1-2): Andrea Mencarelli, Maurizio Vacca, Hanif Javanmard Khameneh, Enzo Acerbi, Alicia Tay, Francesca Zolezzi, Michael Poidinger, and Alessandra Mortellaro. Calcineurin b in cd4+ t cells prevents autoimmune colitis by negatively regulating the jak/stat pathway. Frontiers in Immunology, Feb 2018. URL: https://doi.org/10.3389/fimmu.2018.00261, doi:10.3389/fimmu.2018.00261. This article has 17 citations and is from a peer-reviewed journal.
(reed2020deletionofcalcineurin pages 1-7): Chelsey B. Reed, Luciana R. Frick, Adam Weaver, Mariapaola Sidoli, Elizabeth Schlant, M. Laura Feltri, and Lawrence Wrabetz. Deletion of calcineurin in schwann cells does not affect developmental myelination, but reduces autophagy and delays myelin clearance after peripheral nerve injury. The Journal of Neuroscience, 40:6165-6176, Jul 2020. URL: https://doi.org/10.1523/jneurosci.0951-20.2020, doi:10.1523/jneurosci.0951-20.2020. This article has 48 citations.
(xia2024smurf1controlsthe pages 8-11): Qin Xia, Hanfei Zheng, Yang Li, Wanting Xu, Chengwei Wu, Jiachen Xu, Shanhu Li, Lingqiang Zhang, and Lei Dong. Smurf1 controls the ppp3/calcineurin complex and tfeb at a regulatory node for lysosomal biogenesis. Autophagy, 20:735-751, Nov 2024. URL: https://doi.org/10.1080/15548627.2023.2267413, doi:10.1080/15548627.2023.2267413. This article has 30 citations and is from a domain leading peer-reviewed journal.
(mencarelli2018calcineurinbin pages 10-11): Andrea Mencarelli, Maurizio Vacca, Hanif Javanmard Khameneh, Enzo Acerbi, Alicia Tay, Francesca Zolezzi, Michael Poidinger, and Alessandra Mortellaro. Calcineurin b in cd4+ t cells prevents autoimmune colitis by negatively regulating the jak/stat pathway. Frontiers in Immunology, Feb 2018. URL: https://doi.org/10.3389/fimmu.2018.00261, doi:10.3389/fimmu.2018.00261. This article has 17 citations and is from a peer-reviewed journal.
(mencarelli2018calcineurinbin pages 2-3): Andrea Mencarelli, Maurizio Vacca, Hanif Javanmard Khameneh, Enzo Acerbi, Alicia Tay, Francesca Zolezzi, Michael Poidinger, and Alessandra Mortellaro. Calcineurin b in cd4+ t cells prevents autoimmune colitis by negatively regulating the jak/stat pathway. Frontiers in Immunology, Feb 2018. URL: https://doi.org/10.3389/fimmu.2018.00261, doi:10.3389/fimmu.2018.00261. This article has 17 citations and is from a peer-reviewed journal.
(heineke2010cib1isa pages 4-6): Joerg Heineke, Mannix Auger-Messier, Robert N Correll, Jian Xu, Matthew J Benard, Weiping Yuan, Helmut Drexler, Leslie V Parise, and Jeffery D Molkentin. Cib1 is a regulator of pathological cardiac hypertrophy. Jul 2010. URL: https://doi.org/10.1038/nm.2181, doi:10.1038/nm.2181. This article has 122 citations and is from a highest quality peer-reviewed journal.
(heineke2010cib1isa pages 6-7): Joerg Heineke, Mannix Auger-Messier, Robert N Correll, Jian Xu, Matthew J Benard, Weiping Yuan, Helmut Drexler, Leslie V Parise, and Jeffery D Molkentin. Cib1 is a regulator of pathological cardiac hypertrophy. Jul 2010. URL: https://doi.org/10.1038/nm.2181, doi:10.1038/nm.2181. This article has 122 citations and is from a highest quality peer-reviewed journal.
(reed2020deletionofcalcineurin pages 21-25): Chelsey B. Reed, Luciana R. Frick, Adam Weaver, Mariapaola Sidoli, Elizabeth Schlant, M. Laura Feltri, and Lawrence Wrabetz. Deletion of calcineurin in schwann cells does not affect developmental myelination, but reduces autophagy and delays myelin clearance after peripheral nerve injury. The Journal of Neuroscience, 40:6165-6176, Jul 2020. URL: https://doi.org/10.1523/jneurosci.0951-20.2020, doi:10.1523/jneurosci.0951-20.2020. This article has 48 citations.
(masaki2022decodingthephosphatase pages 4-5): Takahiro Masaki and Midori Shimada. Decoding the phosphatase code: regulation of cell proliferation by calcineurin. International Journal of Molecular Sciences, 23:1122, Jan 2022. URL: https://doi.org/10.3390/ijms23031122, doi:10.3390/ijms23031122. This article has 35 citations.
(thiel2021ca2+microdomainscalcineurin pages 8-10): Gerald Thiel, Tobias Schmidt, and Oliver G. Rössler. Ca2+ microdomains, calcineurin and the regulation of gene transcription. Cells, 10:875, Apr 2021. URL: https://doi.org/10.3390/cells10040875, doi:10.3390/cells10040875. This article has 77 citations.
(nolze2023calcineurinisa pages 3-4): Alexander Nolze, Sebastian Matern, and Claudia Grossmann. Calcineurin is a universal regulator of vessel function—focus on vascular smooth muscle cells. Cells, 12:2269, Sep 2023. URL: https://doi.org/10.3390/cells12182269, doi:10.3390/cells12182269. This article has 24 citations.